The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19
- PMID: 33220127
- PMCID: PMC7753513
- DOI: 10.1111/ene.14652
The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19
Abstract
The COVID-19 pandemic is a global public health issue. Neurological complications have been reported in up to one-third of affected cases, but their distribution varies significantly in terms of prevalence, incidence and phenotypical characteristics. Variability can be mostly explained by the differing sources of cases (hospital vs. community-based), the accuracy of the diagnostic approach and the interpretation of the patients' complaints. Moreover, after recovering, patients can still experience neurological symptoms. To obtain a more precise picture of the neurological manifestations and outcome of the COVID-19 infection, an international registry (ENERGY) has been created by the European Academy of Neurology in collaboration with European national neurological societies and the Neurocritical Care Society and Research Network. ENERGY can be implemented as a stand-alone instrument for patients with suspected or confirmed COVID-19 and neurological findings or as an addendum to an existing registry not targeting neurological symptoms. Data are also collected to study the impact of neurological symptoms and neurological complications on outcomes. The variables included in the registry have been selected in the interests of most countries, to favour pooling with data from other sources and to facilitate data collection even in resource-poor countries. Included are adults with suspected or confirmed COVID-19 infection, ascertained through neurological consultation, and providing informed consent. Key demographic and clinical findings are collected at registration. Patients are followed up to 12 months in search of incident neurological manifestations. As of 19 August, 254 centres from 69 countries and four continents have made requests to join the study.
Keywords: COVID-19; EAN; SARS-CoV-2; complications; neurological diseases; outcome; registry.
© 2020 European Academy of Neurology.
Conflict of interest statement
None declared.
Figures
Similar articles
-
The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future.Eur J Neurol. 2025 Jan;32(1):e16321. doi: 10.1111/ene.16321. Epub 2024 Apr 26. Eur J Neurol. 2025. PMID: 38676302 Free PMC article.
-
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.JAMA Netw Open. 2021 May 3;4(5):e2112131. doi: 10.1001/jamanetworkopen.2021.12131. JAMA Netw Open. 2021. PMID: 33974053 Free PMC article.
-
European Academy of Neurology 2019 - 2022.Eur J Neurol. 2022 Sep;29(9):2567-2571. doi: 10.1111/ene.15421. Epub 2022 Jun 24. Eur J Neurol. 2022. PMID: 35615781 Review.
-
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19.Eur J Neurol. 2022 Jun;29(6):1663-1684. doi: 10.1111/ene.15293. Epub 2022 Mar 7. Eur J Neurol. 2022. PMID: 35194889 Free PMC article.
-
COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.Adv Exp Med Biol. 2021;1353:197-215. doi: 10.1007/978-3-030-85113-2_11. Adv Exp Med Biol. 2021. PMID: 35137375 Review.
Cited by
-
Comparative features and outcomes of major neurological complications of COVID-19.Eur J Neurol. 2023 Feb;30(2):413-433. doi: 10.1111/ene.15617. Epub 2022 Dec 7. Eur J Neurol. 2023. PMID: 36314485 Free PMC article.
-
What the Aftermath of the Global Pandemic Will Mean for Neurologists.Neurol Int. 2021 Jul 9;13(3):297-303. doi: 10.3390/neurolint13030030. Neurol Int. 2021. PMID: 34287348 Free PMC article.
-
Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey.Eur J Neurol. 2022 Jan;29(1):318-323. doi: 10.1111/ene.15087. Epub 2021 Oct 5. Eur J Neurol. 2022. PMID: 34463009 Free PMC article.
-
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review.
-
Associations of the neutrophil/lymphocyte ratio, monocyte/ lymphocyte ratio, and platelet/lymphocyte ratio with COVID-19 disease severity in patients with neurological symptoms: A cross-sectional monocentric study.J Neurosci Rural Pract. 2023 Apr-Jun;14(2):224-229. doi: 10.25259/JNRP_6_2022. Epub 2022 Oct 22. J Neurosci Rural Pract. 2023. PMID: 37181197 Free PMC article.
References
-
- Michalicová A, Bhide K, Bhide M, Kováč A. How viruses infiltrate the central nervous system. Acta Virol. 2017;61(4):393‐400. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous